Cryoport is a global provider of integrated, temperature-controlled supply chain solutions for life sciences, with a primary focus on the cell and gene therapy market. The company operates through three complementary business units—Cryoport Systems, which delivers temperature-controlled logistics and fulfillment services; CryoGene, which provides long-term biostorage; and MVE Biological Solutions, which manufactures cryogenic equipment—serving biopharmaceutical companies, pharmaceutical firms, academic institutions, and government agencies. Revenue is generated through both services and product sales, with the company's Cryoportal digital platform and Chain of Compliance framework providing end-to-end, regulatory-compliant handling from preclinical development through commercial deployment, positioning it as a comprehensive solution provider for the rapidly expanding cell and gene therapy market.